4-Hydroxyphenylboronic acid | CAS:71597-85-8

We serve 4-Hydroxyphenylboronic acid CAS:71597-85-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Hydroxyphenylboronic acid

Product Name: 4-Hydroxyphenylboronic acid
Other Name:
4-Hydroxyphenylboronic acid
(4-hydroxyphenyl)boronic acid
CAS No: 71597-85-8
MF: C6H7BO3
MW: 137.92900
Density: 1.32 g/cm3
Boiling point: 351.4ºC at 760 mmHg
Melting point: >230 °C(lit.)
Flash point: 166.3ºC
UN Number: Not dangerous goods.
UN Proper Shipping Name: Not dangerous goods.
Transport hazard class: Not dangerous goods.
Packing group: Not dangerous goods.
 
Specification
Appearance: Off-white to light brown powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Applicationd in OLED intermediates, pharmaceutical intermediate.
Mainly used in Suzuki coupling reactions.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 4-Hydroxyphenylboronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(4-hydroxyphenyl)boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Hydroxyphenylboronic acid Use and application,4-Hydroxyphenylboronic acid technical grade,usp/ep/jp grade.


Related News: After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply.N-(4-methylpentan-2-ylidene)hydroxylamine manufacturer The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.2-Bromophenylboronicacid supplier Is there a cure? Not at the moment. Researchers have successfully grown the virus in a lab, an important step towards developing a vaccine — but it could be a year or more until it’s available.1-naphthyl isothiocyanate vendor Is there a cure? Not at the moment. Researchers have successfully grown the virus in a lab, an important step towards developing a vaccine — but it could be a year or more until it’s available.Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list.